Thomson / British Thoracic Oncology Group / Puterman A.S. / /
Country
Hungary / Italy / Macedonia / Poland / Colombia / United States / China / /
Event
FDA Phase / /
IndustryTerm
treatment of non-smallcell lung cancer / treatment of non-small cell lung cancer / treatment of acute respiratory tract diseases / /
MedicalCondition
lethal West Nile virus infection / COPD / acute respiratory tract diseases / epidemic / advanced and metastatic non-small cell lung cancer / persistent asthma / O.D. Pediatric Asthma / West Nile virus encephalitis / metastatic non-small cell lung cancer / non-small-cell lung cancer / non-small cell lung cancer / A/B non-small cell lung cancer / advanced non-small cell lung cancer / O.D. Pediatric Allergy / Skin manifestations / M. Lung Cancer / advanced non-small-cell lung cancer / asthma / IV non-small cell lung cancer / N. Clinical Lung Cancer / Cancer / Z. Lung Cancer / West Nile virus infection / unresectable non small cell lung carcinoma / non-smallcell lung cancer / III non-small cell lung cancer / J.P. Lung Cancer / Allergy / viral infections / Lung Cancer / advance non-small cell lung cancer / bronchiectasis / J.H. Lung Cancer / A. Lung Cancer / /
ANEXANumăr de citări în reviste de specialitate cotate ISI 1 Denumire Articol Clinical effects of erdosteine in the treatment